Original language | English |
---|---|
Pages (from-to) | 419-420 |
Journal | Multiple Sclerosis Journal |
Volume | 22 |
Issue number | 3 |
Publication status | Published - 2016 |
Efficacy and Safety of Natalizumab in Multiple Sclerosis: Interim Observational Program Results from an Australian Cohort
H. Butzkueven, M. Barnett, S. Broadley, S. Hodgkinson, J. King, C. Kneebone, M. Slee, J. Lechner-Scott, A. Kermode, N. Shuey, R. Macdonell, Y. Chen, K. Naidoo, H. Koendgen
Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review